The listed company that produces the new crown antigen kit is Wuhan Shengzhiyuan Biotechnology Co.
In the assembly workshop, a long white test card in turn after sorting, cutting strips, to complete the manual assembly link. May 4, in the national biological industry base medical device technology enterprises, gas pedal in Wuhan, the source of biological science and technology limited company, is stepping up the production of the new crown virus antigen test kit has just been approved.
Currently, the daily production capacity has reached 8 million to 10 million people, the first batch of packaging materials are already in place to realize offline sales. In the future, the public will be able to buy them through online platforms or pharmacies. The Provincial Drug Administration has initiated an emergency approval mechanism under the premise of ensuring that the process is complete and rigorous. The registration application materials of Shengzhiyuan were verified five times, all of which were uploaded on the same day and the verification work was completed, and the verification letter was issued within 24 hours. After obtaining the registration certificate, the company was assisted to complete the change of production license in the first time.
Product introduction:
New coronavirus antigen self-testing kit is a new coronavirus antigen self-testing products, according to the National Health Insurance Bureau issued a "notice", the drug ball each provincial health insurance department should be in accordance with the procedures of the new coronavirus antigen detection reagents and the corresponding test items, temporary inclusion in the province's basic health insurance medical services catalog. Public medical institutions to carry out the new coronavirus antigen test reagents to implement zero-differential rate, in accordance with the provisions of the Tianjin pharmaceutical procurement platform procurement.
Non-public medical institutions and third-party testing organizations to provide antigen detection services, pricing should follow the principles of fairness, legality and honesty and credit, reflecting the preservation of capital and micro-benefits. The masses simply test antigen, public medical institutions are exempt from outpatient consultation fees. Patient self-testing, public medical institutions shall not charge the new coronavirus antigen detection program costs and other price policies.